---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-029705"
form_type: "8-K"
ticker: "KURA"
cik: "0001422143"
company_name: "Kura Oncology, Inc."
filed_at: "2026-01-29T23:59:59+00:00"
generated_at: "2026-05-16T06:22:26.971373+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Kura Oncology amends bylaws to update advance notice, quorum, indemnification provisions

## Summary
- Updated advance notice: annual meeting date shift threshold extended to >70 days (previously 30) before alternative notice window applies.
- Quorum threshold changed from majority of outstanding shares to majority of voting power; default approval changed to majority of votes cast.
- Incorporated universal proxy rules (Rule 14a-19); limited shareholder nominations to number of directors to be elected, no substitute nominees.
- Enhanced forum selection: Delaware federal courts as backup for state court actions; added exclusive forum for Securities Act claims.
- Expanded mandatory indemnification for directors/officers to maximum extent allowed by law; added expense advancement procedures.

## SEC filing metadata
- accession: 0001193125-26-029705
- form_type: 8-K
- ticker: KURA
- cik: 0001422143
- company_name: Kura Oncology, Inc.
- filed_at: 2026-01-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422143/000119312526029705/0001193125-26-029705-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422143/000119312526029705/d18498d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-029705
- JSON: https://secwatch.observer/filing/0001193125-26-029705.json
- Plain text: https://secwatch.observer/filing/0001193125-26-029705.txt

## Source-grounded claims
- claim_id: db1ea66c9ef2bd710a9d1b01e31577b92b49ca7a
  claim: Kura Oncology, Inc.: The Board adopted amended and restated bylaws effective January 28, 2026, making numerous changes to stockholder meeting procedures, advance notice requirements, quorum and voting thresholds, and other governance provisions (effective 2026-01-28).
  evidence_excerpt: On January 28, 2026, the board of directors (the “Board”) of Kura Oncology, Inc. (the “Company”) adopted amended and restated bylaws of the Company (as amended and restated, the “A&R Bylaws”), effective as of such adoption date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1422143/000119312526029705/0001193125-26-029705-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.